Novel chimeric parapoxvirus CF189 as an oncolytic immunotherapy in triple-negative breast cancer

Triple-negative breast cancer is an aggressive subtype of breast cancer with high recurrence rate and poor prognosis. Here we describe a novel, genetically engineered parapoxvirus that efficiently kills triple-negative breast cancer.

Source: Surgery - November 22, 2017 Category: Surgery Authors: Audrey H. Choi, Michael P. O'Leary, Shyambabu Chaurasiya, Jianming Lu, Sang-In Kim, Yuman Fong, Nanhai G. Chen Tags: Society of University Surgeons Source Type: research